Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Panacea Life Sciences HoldingsPLSH 3-Year Share Buyback Ratio is -6.10 as of Sep. 2025. The stock has 6 warning signs investors should review. Among 645 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks worse than 64.5% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Panacea Life Sciences Holdings's current 3-Year Share Buyback Ratio was -6.10%.
The historical rank and industry rank for Panacea Life Sciences Holdings's 3-Year Share Buyback Ratio or its related term are showing as below:
PLSH'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -6.1 Med: -6.1 Max: -6.1
Current: -6.1
During the past 4 years, Panacea Life Sciences Holdings's highest 3-Year Share Buyback Ratio was -6.10%. The lowest was -6.10%. And the median was -6.10%.
PLSH's 3-Year Share Buyback Ratio is ranked worse than 64.5% of 645
companies
in the Drug Manufacturers industry
Industry Median: -1.9
vs PLSH: -6.10
Panacea Life Sciences Holdings (OTCPK:PLSH) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Panacea Life Sciences Holdings 3-Year Share Buyback Ratio Related Terms
PLSH vs SKYI, IMCC, CBDY: 3-Year Share Buyback Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings 3-Year Share Buyback Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's 3-Year Share Buyback Ratio falls into.
Panacea Life Sciences Holdings 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -6.10 mean?
Panacea Life Sciences Holdings (PLSH) has a 3-Year Share Buyback Ratio of -6.10 as of Sep. 2025. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Panacea Life Sciences Holdings and its competitors. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #416 out of 645 companies in the Drug Manufacturers industry, placing it in the top 64.5%.
Is Panacea Life Sciences Holdings' 3-Year Share Buyback Ratio too high?
Panacea Life Sciences Holdings' current 3-Year Share Buyback Ratio is -6.10. Based on the distribution chart, Panacea Life Sciences Holdings ranks #416 out of 645 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Panacea Life Sciences Holdings' 3-Year Share Buyback Ratio compare to SKYI and IMCC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #416 out of 645 companies for 3-Year Share Buyback Ratio. This places Panacea Life Sciences Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current 3-Year Share Buyback Ratio is -6.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current 3-Year Share Buyback Ratio of -6.10. The current 3-Year Share Buyback Ratio is -6.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current 3-Year Share Buyback Ratio is -6.10 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 
